Elisabeth Heath

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (Specialty Not Specified)
    Ineligible company: 
    Oncolys
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    10/20/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (Specialty Not Specified)
    Ineligible company: 
    Agensys
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    10/20/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (Specialty Not Specified)
    Ineligible company: 
    Merck
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    10/20/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Specialty Not Specified)
    Ineligible company: 
    Zenith
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    10/20/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Seattle Genetics
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    10/20/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Sanofi
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    10/20/2023
Return to Update Series (2023) Lesson 12: Adjuvant and Early Salvage Therapy Recommendations Following Radical Surgery in Urologic Cancers